PKMYT1 (Gene)

Synonyms:ENTREZ:9088, HGNC:29650, MIM:602474, MYT1, NM_001258450, NM_001258451, NM_004203, NM_182687, NP_001245379, NP_001245380, NP_004194, NP_872629, PKMYT1, PPP1R126, XM_011522734, XM_011522735, XM_011522736, XM_024450490, XP_011521036, XP_011521037, XP_011521038, XP_024306258, protein kinase, membrane associated tyrosine/threonine 1
Omim:OMIM:602474
Id:ENSG00000127564
Hgnc:HGNC:29650
Entrez:9088
Description:protein kinase, membrane associated tyrosine/threonine 1
This gene encodes a member of the serine/threonine protein kinase family. The encoded protein is a membrane-associated kinase that negatively regulates the G2/M transition of the cell cycle by phosphorylating and inactivating cyclin-dependent kinase 1. The activity of the encoded protein is regulated by polo-like kinase 1. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View PKMYT1's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with PKMYT1.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using PKMYT1.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for PKMYT1.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with PKMYT1.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.